Significant Ownership of GSK plc

Signature - Title
/s/ Victoria A. Whyte - Victoria A. Whyte, Authorized Signatory
Location
London
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by GSK plc.

Follow Filing Activity

Follow GSK plc and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Significant Ownership of GSK plc

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SPRO SPERO THERAPEUTICS, INC. Common Stock, Par Value $0.001 16% $6,709,142 9,190,606 GSK PLC 27 Mar 2025
CVAC CureVac N.V. Common Shares, par value (euro) 0.12 per share 0% $0 -$87,937,266 0 -100% GSK plc 03 Dec 2025

Schedules 13D/G Reported by GSK plc:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .